ConvaTec Group (CNVVY) Projected to Post Quarterly Earnings on Wednesday

ConvaTec Group (OTCMKTS:CNVVY) is projected to announce its results before the market opens on Wednesday, February 25th. Analysts expect the company to announce earnings of $0.40 per share and revenue of $1.2526 billion for the quarter.

ConvaTec Group Stock Performance

CNVVY opened at $12.40 on Tuesday. ConvaTec Group has a twelve month low of $11.28 and a twelve month high of $16.65. The company has a 50-day moving average price of $12.73 and a 200 day moving average price of $12.71.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on CNVVY. Peel Hunt upgraded ConvaTec Group from a “moderate buy” rating to a “strong-buy” rating in a research report on Tuesday, October 28th. Sanford C. Bernstein upgraded ConvaTec Group to a “strong-buy” rating in a report on Wednesday, January 28th. Two investment analysts have rated the stock with a Strong Buy rating, According to MarketBeat, ConvaTec Group has a consensus rating of “Strong Buy”.

ConvaTec Group Company Profile

ConvaTec Group is a global medical products and technologies company focused on developing therapies and technologies for the management of chronic health conditions. The company’s portfolio spans four core business areas—Advanced Wound Care, Ostomy Care, Continence & Critical Care, and Infusion Devices—which are designed to improve patient outcomes and enhance quality of life for people living with long-term health challenges. ConvaTec’s product range includes proprietary wound dressings, ostomy and continence management systems, and safety-engineered infusion sets.

Headquartered in Reading, United Kingdom, ConvaTec serves customers in over 100 countries through a network of manufacturing, distribution, and customer support operations.